EVQLV
Biotechnology ResearchNew York, United States2-10 Employees
EVQLV is a biotechnology research company based in New York, New York, focused on accelerating the design and development of therapeutic antibodies through computational approaches. Its work spans early discovery to optimization, helping partners speed antibody discovery and refine candidates to expand intellectual property protection and enable next-generation immunotherapies, all by leveraging large, diverse datasets and scalable computational methods. The company serves collaborators at various stages—from discovery to preclinical or clinical development—providing support that aims to shorten development timelines and enhance asset optimization. While operating in a specialized niche of antibody design, EVQLV positions itself within the biotech and computational biology space by combining data-driven design with therapeutic advancement. A recent development noted in public announcements is the launch of Abtique, an online marketplace that enables scientists to order synthesis-ready antibody sequences directly from the platform.
1-888-653-2347 
support@leadiq.com 
